SC
TGTX icon

Syon Capital’s TG Therapeutics TGTX Stock Holding History

Syon Capital’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$451K Buy
8,210
+45
+0.6% +$1.84K 0.02% 663
2026
Q1 		$271K Sell
8,165
-336
-4% -$10K 0.01% 769
2025
Q4 		$253K Sell
8,501
-41
-0.5% -$1.34K 0.01% 791
2025
Q3 		$309K Sell
8,542
-2,691
-24% -$88.6K 0.02% 647
2025
Q2 		$404K Sell
11,233
-1,502
-12% -$55.9K 0.03% 448
2025
Q1 		$502K Buy
12,735
+3,578
+39% +$120K 0.04% 311
2024
Q4 		$276K Buy
+9,157
New +$263K 0.02% 422

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Syon Capital's TGTX Position: Q2 2026 in Review

Syon Capital increased its TG Therapeutics (TGTX) stake by 0.55% in Q2 2026, buying an estimated $1.84K and bringing the position to 8,210 shares worth $451K. The position accounts for 0.02% of the portfolio, ranked #663.

Syon Capital first reported a position in TGTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $502K in Q1 2025. 428 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Syon Capital held 8,210 shares of TG Therapeutics worth $451K as of Q2 2026.
  • Syon Capital bought 45 TG Therapeutics shares in Q2 2026, an estimated $1.84K.
  • TG Therapeutics made up 0.02% of Syon Capital's portfolio in Q2 2026, its #663 holding.
  • Syon Capital first reported a position in TG Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Syon Capital's TG Therapeutics position peaked at $502K in Q1 2025.
  • 428 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.